Overcoming Challenges in the Treatment and Management of Cytomegalovirus

A continuing medical education activity sponsored by NAMCP and AAMCN.

Confronting the Burden of Serious Infections: Managed Care Considerations in an Evolving
Treatment Landscape is a 3-part webcast series that will provide critical updates on the
advances of antimicrobial use in serious infections, including how to translate the most
recent data into clinical and administrative practice.

This is Part 1 of the series focusing on the Treatment and Management of Cytomegalovirus

This activity is an archive from the webinar held August 27, 2019

This activity is valid from October 1, 2019 to October 1, 2021

Instructions for CME/CNE: Complete the pre-test, listen to the audio and view the slides, complete the post test, complete the evaluation form and hit submit. You will be asked to enter your name and email address on the pre-test, evaluation and post-test. If you close your internet browser without completing the post test, you will have ONE more opportunity to complete. A score of 70% must be achieved on the post test to receive continuing education credits. If you do not pass the post test after two attempts, you will not be eligible to try again. Once you complete the evaluation form and score 70% or higher on your post test, you will automatically be given your certificate.

To print or save your certificate, you will need to click on the “download” button and either print or save.


Audience: This activity is intended for healthcare professionals practicing in managed care environments.

This presentation is supported by an educational grant from
Merck Sharp & Dohme Corp.

Infections caused by Gram-negative bacteria, C. Difficile bacterium, and Cytomegalovirus (CMV) are a significant concern and can have serious consequences. These infections are increasing in prevalence, and their management is complicated by limited treatment options. New clinical practice guidelines are out and clinical best practices for optimal treatment of these challenging clinical situations will be discussed by experts in the infectious disease field, within the wider clinical context of responsible antimicrobial stewardship and managed care decision making. Each webinar will offer a new, specific view into the evolving management paradigm of serious infections, especially as it relates to overcoming barriers found amongst clinicians and managed care professionals.

Upon completion of this activity, participants will be able to:

  • Describe the clinical and economic burden of Cytomegalovirus (CMV) in HSCT patients and the impact of these burdens on optimal management

  • Examine prophylactic measures for CMV in patients undergoing HSCT using evidence-based therapeutic approaches

  • Analyze the efficacy and safety of available and emerging treatment strategies for prevention of recurrent CMV in patients undergoing HSCT based on evidence-based therapeutic approaches

  • Identify patients who may benefit from antiviral treatment for CMV infection

  • Optimize clinical and economic strategies in the prevention of CMV in HSCT recipients

Faculty: Camille Nelson Kotton, MD, FIDSA, FAST
Clinical Director, Transplant and Immunocompromised Host Infectious Diseases
Infectious Diseases Division
Massachusetts General Hospital
Associate Professor, Harvard Medical School


Dr. Kotton serves as a consultant for COGEN Therapeutics, GSK, Hookipa, Merck, Oxford Immunotec, Qiagen, Shire-Takeda. She has served as an advisory board member for Merck and Shire-Takeda. She has in the past received grant or research support from Hookipa and Oxford Immunotec. Her presentation has been peer reviewed for any bias.
  Planning Committee:
Bill Williams, MD has no relevant financial relationships to disclose.
Jeremy Williams has no relevant financial relationships to disclose.
Will Williams has no relevant financial relationships to disclose.
Jacqueline Cole, RN, MS, CMCN has no relevant financial relationships to disclose.

NAMCP and/or the presenter has copyright or has received permissions for use of materials provided in this activity.

Accreditation & Designation
The National Association of Managed Care Physicians (NAMCP) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

NAMCP designates this enduring material for a maximum of 1 AMA PRA Category I creditsTM.

The American Association of Managed Care Nurses (AAMCN) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation (ANCC).

Nurses who complete this activity and achieve a passing score will receive 1 hour in continuing
nursing credit.

This activity has been approved by the American Board of Managed Care Nursing for 1.0 contact hour toward CMCN recertification requirements.

This presentation is supported by an educational grant from
Merck Sharp & Dohme Corp.

NAMCP and/or this website does not provide medical advice, diagnosis or treatment. NAMCP does not endorse or imply endorsement of the content on any linked website. This website is to be used as an informational resource. With any health related concern, consult with your physician or healthcare professional.

Click Here To Continue